Health News

AVAC today issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible. The call comes as a group of microbicide and public health experts have agreed upon a plan for further studies, which are expected to cost $100 million over three years, of which only $58 million has been committed.

Read more

Filed under: Pharmacy News
Tags: donors, Pharmacy

Related posts

• The role of pharmaceutical companies in global health (0)
  Owen Barder, a visiting fellow at the Center for Global Development, examines the relationship among aid donors, GAVI and pharmaceutical companies in a post on the center's "Global Health Policy" blog. Read more [tags] Pharmacy News [/tags]
  
  
• Taiwanese hemophiliacs infected by HIV-contaminated medications petition US Supreme Court (0)
  Baum Hedlund announces that Taiwanese hemophiliacs infected by HIV-contaminated medications have petitioned the United States Supreme Court to allow their claims to proceed in California. Their suits contend that California-based defendants illegally used paid plasma donors at high risk for transmitting blood-borne diseases (i.v. drug users, prisoners, and promiscuous urban gay males) to make injected [...]
  
  
• SanBio Receives FDA Clearance To Initiate Cell Therapy Clinical Studies For Stroke Recovery (0)
  SanBio Inc. announced that the United States Food and Drug Administration (FDA) has approved the clinical testing of their SB623 regenerative medicine product in patients suffering from disability caused by cerebral stroke. SB623 is derived from bone marrow stromal cells (MSCs) isolated from healthy adult donors... Read more [tags] Pharmacy News [/tags]
  
  
• MSF report warns of effects of international donor ‘backtracking’ in global fight against HIV/AIDS (0)
  "Backtracking by international donors in funding for HIV/AIDS may undermine years of progress and is already putting lives at risk," according to a report released Thursday by Medecins Sans Frontieres, Reuters reports (Kelland, 5/27). Read more [tags] Pharmacy News [/tags]
  
  
• Major donors should consider funding for potential malaria vaccine (0)
  When the results of a large clinical trial testing the effectiveness of the RTS,S malaria vaccine among children in Africa are made available later this year, "it will be time to start discussing what to do with the vaccine," Orin Levine, executive director of the International Vaccine Access Center at Johns Hopkins University, writes in [...]